Results 161 to 170 of about 4,694,538 (359)
PROSPECTS FOR SEAWATER DESALINATION WITH NUCLEAR ENERGY. AN EVALUATION PROGRAM [PDF]
Gale Young, Roy Hammond, I. Spiewak
openalex +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Is program evaluation just a “necessary evil” for Extension program implementation? Or, rather, an opportunity to identify and document accomplishments and discover ways to strengthen the impact of programs? This 5-page fact sheet defines evaluation, explains why evaluation is important to Extension programming beyond accountability requirements ...
Alexa J. Lamm+3 more
openaire +3 more sources
Dynamic Evaluation of Job Search Assistance [PDF]
This paper evaluates a job search assistance program for unemployment insurance recipients. The assignment to the program is dynamic. We provide a discussion on dynamic treatment effects and identification conditions.
Kastoryano, Stephen, van der Klaauw, Bas
core
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source
Centers for Disease Control and Prevention Harvard Program Evaluation Practicum: 10 Years of Partnership in Public Health Program Evaluation. [PDF]
Ramsey LM+8 more
europepmc +1 more source
Evaluation of homemaker service programs in Massachusetts.
Anna Neumann, Marjorie A. C. Young
openalex +2 more sources
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche+8 more
wiley +1 more source
Framework for the cost benefit analysis of the NSW Department of Community Services Brighter Futures Program. CHERE Working Paper 2009/4. [PDF]
Brighter Futures is the NSW DOCS early intervention program targeting children aged 0 to 8. The program is designed to ?support pregnant women and families with young children aged 0-8 years who require long-term support (up to two years) by a range of ...
Gisselle Gallego+4 more
core